Comment on "A severe linezolid-induced rhabdomyolysis and lactic acidosis in Leigh syndrome".

Address: Department of Clinical Medicine, University of Bergen, Bergen, Norway.; Department of Neurology, Haukeland University Hospital, Bergen, Norway.; Department of Human Nutrition, Foods, and Exercise and the Virginia Tech Center for Drug Discovery, Virginia Tech, Blacksburg, Virginia, USA.; Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.; Genetics Unit. Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Mitochondrial Research Group, UCL Great Ormond Street Institute of Child Health, and Metabolic Unit, Great Ormond Street Hospital NHS Foundation Trust, London, UK.; Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.; Department of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, Italy.; Department of Neurology, Metabolic Unit. Hospital Sant Joan de Déu, Barcelona, Spain. CIBERER, Instituto de Salud Carlos III, Barcelona, Spain.; MRC Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, United Kingdom.; Department of Pharmacology and Toxicology, Radboud Institute for Molecular Life Sciences, Radboud Center for Mitochondrial Medicine, Radboudumc, Nijmegen, The Netherlands.; Department of Clinical Medicine, University of Bergen, Bergen, Norway.; Radboudumc Amalia Children's Hospital, Radboud Center for Mitochondrial Medicine, Radboudumc, Nijmegen, The Netherlands.